Figure 1 | Laboratory Investigation

Figure 1

From: DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury

Figure 1

Time course of DPPIV activity in various organs and effects of DA-1229 on DPPIV activity. (a) DPPIV activity in plasma and various organs over time. (b) DPPIV activity in the plasma after 3 months of treatment with DA-1229. (c) DPPIV activity in various organs after 3 months of treatment with DA-1229. Values are expressed as means±s.e.m. Statistical analysis was performed between different groups at the same time points. *P<0.05, **P<0.01, ***P<0.001 vs db/m group; #P<0.05, ##P<0.01, ###P<0.001 vs db/db group.

Back to article page